Proposed FDA Definition Of Custom Devices Will Limit Access, Congressman Says
This article was originally published in The Gray Sheet
Executive Summary
Rep. Marlin Stutzman, R-Ind., tells FDA’s device center in a recent letter the definition of “custom devices” in the agency’s January draft guidance on the topic will unnecessarily limit patient access to the tailor-made products.